Analyst Ratings for Avalo Therapeutics Inc. (AVTX)
AVTX Rating Summary
AVTX Price Target Summary
- Highest: $50.00 (Guggenheim)
- Lowest: $25.00 (H.C. Wainwright)
- Average: $37.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$37.50 (+116.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$37.50 (+116.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2026 | Guggenheim | Yatin Suneja | New Coverage | Buy (N/A) |
50.00 (N/A) |
15.11 (17.31) |
14.56% | Details |
| 12/18/2025 | Mizuho | Joseph Catanzaro | New Coverage | Outperform (N/A) |
39.00 (N/A) |
18.82 (17.31) |
-8.02% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
